http://www.theaidsreader.com AIDS and HIV News and Information - The AIDS Reader en Copyright 2009, CMPMedica US Sat, 19 May 2012 06:00:01 GMT Sat, 19 May 2012 06:00:01 GMT http://blogs.law.harvard.edu/tech/rss http://www.theaidsreader.com/display/article/1145619/2072663?CID=rss HIV and AIDS are becoming more common among people over 50, for many reasons. Providing adequate treatment can be a challenge. New guidelines are here to help. Tue, 15 May 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2072605?CID=rss <img width="78" height="100" src="http://www.theaidsreader.com/image/image_gallery?img_id=2072603&t=1337098782937" alt="" border="0" align="left" style="padding-right:5px;" />Whether Mom or infant takes the drugs, antiretrovirals during the first 6 months protect breast-fed infants against contracting HIV. In this interview, the lead author of the CDC-led study discusses the implications.<br style="clear:both;"/> Tue, 15 May 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2064707?CID=rss <img width="81" height="100" src="http://www.theaidsreader.com/image/image_gallery?img_id=2064600&t=1335378696197" alt="" border="0" align="left" style="padding-right:5px;" />There's no need to abandon abacavir as an option for AIDS treatment fearing adverse effects. This podcast features a new guideline that shows how to use easily ordered genetic tests to judge who can take the drug safely.<br style="clear:both;"/> Wed, 25 Apr 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2062783?CID=rss New guidelines on the use of antiretroviral therapy, together with recently published studies, highlight the benefits of early, short-term treatment on outcomes, clinical signs of the disease, morbidity and mortality, and secondary transmission. Fri, 20 Apr 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2061240?CID=rss A recent approval of an antiretroviral for children with HIV highlights the difficulties in treatment for pediatric HIV, which is not entirely eliminated in the US and tragically abundant elsewhere. It's also important for HIV among adolescents, which remains a concern in the US. Wed, 18 Apr 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2056776?CID=rss <img width="65" height="90" src="http://www.theaidsreader.com/image/image_gallery?img_id=2057003&t=1334007880167" alt="" border="0" align="left" style="padding-right:5px;" />More than half of people with HIV infection in the United States develop head and neck lesions. Common among these is enlargement of the parotid gland, which causes disfigurement and therefore distress. This review discusses the evidence for radiation treatment as the best option, as well as the dangers of choosing the wrong treatment for this benign comorbidity of HIV-positive status.<br style="clear:both;"/> Mon, 9 Apr 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2048935?CID=rss By starting patients on antiretroviral therapy (ART) before infection, researchers theorize, the drugs may inhibit HIV replication immediately after exposure to the virus. But adherence by uninfected individuals is a major challenge. Thu, 15 Mar 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2048927?CID=rss At the 19th Annual Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, much of the discussion focused on issues secondary to HIV: cardiovascular comorbidities and hepatitis. Mon, 19 Mar 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2048917?CID=rss US government guidelines tell how to treat HIV/AIDS effectively, but fewer than a third of patients achieve complete viral suppression. New recommendations from an independent association of physicians and other healthcare providers now recommend ways to be sure that HIV-positive individuals adhere to treatment and remain in care. Tue, 20 Mar 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2037311?CID=rss Infants of nevirapine-treated mothers have a fourfold lower rate of postnatal HIV transmission. Fri, 24 Feb 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2037161?CID=rss Two promising new drugs for hepatitis C interfere with antiretrovirals, particularly ritonavir. Caution is advised when treating co-infected patients. Wed, 22 Feb 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/2037155?CID=rss An important goal of anti-retroviral therapy is preventing transmission of the virus. The New York State Department of Health AIDS Institute offers detailed new guidance on how to achieve this. Mon, 20 Feb 2012 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/1794377?CID=rss A Roster of HIV/AIDS-Related Resources Wed, 9 Feb 2011 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/1639245?CID=rss Substance abuse, especially injection drug abuse, is often associated with chronic infectious diseases, including HIV infection, hepatitis B, hepatitis C, and tuberculosis. Delivery of effective treatment for these chronic conditions can be very challenging in patients who continue to abuse substances. Fri, 13 Aug 2010 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/1585480?CID=rss How likely is it that an HIV patient's infection will become less severe? A bioinformatics researcher at Drexel University has developed a competition on Kaggle that asks participants to find the markers in an HIV sequence that could predict a change in severity of infection. Thu, 10 Jun 2010 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/1518632?CID=rss <img src="/image/image_gallery?img_id=1518737&t=1265223221750" width="100" style="padding-right:5px;" align="left"/>A 50-year-old African American man with HIV infection had a CD4+ T-cell count of 18/μL (1%), CD8+ cell count of 1035/μL (69%), and CD4:CD8 ratio of 0.01 at the time of diagnosis. He had multiple erythematosquamous skin lesions over his forehead, face, chest, back, and extremities Wed, 3 Feb 2010 12:00:00 GMT http://www.theaidsreader.com/display/article/1145619/1518303?CID=rss In 2006, the CDC recommended “opt-out” routine HIV testing in all health care encounters for persons 13 to 64 years of age. While this recommendation has garnered some support, concerns about the feasibility of such routine testing in a busy office without disrupting patient care has persisted. We report the results of a pilot study to determine the feasibility of routine testing in a busy urban clinic. Tue, 2 Feb 2010 12:00:00 GMT